Cardiovascular risk reduction targets in diabetes

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1430, 2004-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cardiovascular risk reduction in diabetes: underemphasised and overdue. Messages from major trials

By Adler Amanda I

Clinical Medicine, Vol. 1, Iss. 6, 2001-11 ,pp. : 472-477

Royal College Of Physicians

Access to resources Recommend Favorite

Cardiovascular risk and prevention in diabetes mellitus

By Roberts Aled W

Clinical Medicine, Vol. 10, Iss. 5, 2010-10 ,pp. : 495-499

Royal College Of Physicians

Access to resources Recommend Favorite

Cardiovascular Risk Reduction in the Extreme Elderly

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 43, Iss. 1, 2013-03 ,pp. : 62-68

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cardiovascular risk scores improve prescribing in diabetes mellitus

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 398, 2003-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

CARDS: atorvastatin reduces risk of cardiovascular events in diabetes

Inpharma, Vol. 1, Iss. 1446, 2004-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite